HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target

Author(s):
Souri, Z. (0000-0003-2800-8998); Wierenga, A.P.A.; Mulder, A.; Jochemsen, A.G. (0000-0002-0570-7967); Jager, M.J.
Published
2019
Publication type
Article / Letter to editor
uveal melanomainflammationHLA Class IHLA Class IIchromosome 3BAP1
Date issued
2019-08-31
Language
English
Is part of
Cancers (2019), No. 8
hdl
1887/120677
doi
10.3390/cancers11081132